MDWD · NASDAQ
MediWound (MDWD) Stock Price & Fundamentals
MediWound (MDWD) closed at $382.73 on Oct 9, 2026, down 1.66% from the previous close of $389.20.
Share price, past year
1Y +12.32%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $382.73 |
| Sep 30, 2026 | $376.15 |
| Aug 31, 2026 | $382.38 |
| Jul 31, 2026 | $371.85 |
| Jun 30, 2026 | $378.38 |
| May 29, 2026 | $388.68 |
| Apr 30, 2026 | $401.12 |
| Mar 31, 2026 | $409.74 |
| Feb 27, 2026 | $394.14 |
| Jan 30, 2026 | $365.75 |
| Dec 31, 2025 | $374.93 |
| Nov 28, 2025 | $345.79 |
| Oct 31, 2025 | $334.05 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 12.8M
- Dividend yield
- —
- 52-week range
- $329.08 – $416.31
Market cap, P/E and dividend yield aren't shown for MediWound yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US.
Financials
MediWound reported revenue of $16.96M for fiscal 2025, down 16.14% from fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $16.96M | −16.1% | — | — | −$2.10 | −$21.63M |
| FY2024ended Dec 31, 2024 | $20.22M | +8.2% | — | — | −$3.03 | −$19.90M |
| FY2023ended Dec 31, 2023 | $18.69M | −29.5% | — | — | −$0.75 | −$16.93M |
| FY2022ended Dec 31, 2022 | $26.50M | +11.5% | — | — | −$3.93 | −$12.44M |
| FY2021ended Dec 31, 2021 | $23.76M | +9.2% | — | — | −$3.48 | −$9.41M |
| FY2020ended Dec 31, 2020 | $21.76M | −31.5% | — | — | −$2.38 | −$7.82M |
| FY2019ended Dec 31, 2019 | $31.79M | +834.7% | — | — | — | $7.50M |
| FY2018ended Dec 31, 2018 | $3.40M | +36.3% | — | — | — | −$12.68M |
| FY2017ended Dec 31, 2017 | $2.50M | +60.2% | — | — | — | −$17.50M |
| FY2016ended Dec 31, 2016 | $1.56M | — | — | — | — | −$17.12M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | $5.71M | — | −$1.23 |
| Q2 FY2024ended Jun 30, 2024 | $5.06M | — | −$0.68 |
| Q2 FY2023ended Jun 30, 2023 | $4.77M | — | $0.10 |
| Q2 FY2022ended Jun 30, 2022 | $4.67M | — | −$0.92 |
| Q2 FY2021ended Jun 30, 2021 | $6.06M | — | −$0.12 |
| Q2 FY2020ended Jun 30, 2020 | $4.03M | — | — |
| Q2 FY2019ended Jun 30, 2019 | $20.75M | — | — |
| Q2 FY2018ended Jun 30, 2018 | $1.03M | — | — |
Company profile
- Name
- MediWound Ltd.
- Ticker
- MDWD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Medicinal Chemicals & Botanical Products
- Headquarters
- 42 Hayarkon Street, Yavne, L3 8122745
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001593984
Recent SEC filings
- Mar 5, 2026
- Mar 19, 2025
- Mar 21, 2024
- Mar 16, 2023
- Mar 17, 2022
- Feb 25, 2021
- Feb 25, 2020
- Mar 25, 2019
Frequently asked questions
What is MediWound's stock price?
MediWound (MDWD) closed at $382.73 on Oct 9, 2026, down 1.66% from the previous close of $389.20.
How much revenue does MediWound make?
MediWound reported revenue of $16.96M for fiscal 2025, down 16.14% from fiscal 2024.
Sources and methodology
Fundamentals come from MediWound Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures